Recent

% | $
Quotes you view appear here for quick access.

Amarin Corporation plc Message Board

jesse.livermore 7 posts  |  Last Activity: Jul 3, 2015 9:09 AM Member since: Aug 21, 2009
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Stock price movement = total fiction

    by to_the_pain Jun 23, 2015 10:35 PM
    jesse.livermore jesse.livermore Jul 3, 2015 9:09 AM Flag

    PPS = total fiction...eh?.... PPS was $.83 on Nov 10 2014. Thats up 300% in six months buckaroos. That kind of profit would have Warren Buffett dancing the Funky Chicken. Traders are "picking up pennies in front of a steam roller.

    ": ) JL

    Sentiment: Strong Buy

  • Reply to

    Short @$2.47 30,000 shares

    by optionjoe5 Jun 30, 2015 7:13 PM
    jesse.livermore jesse.livermore Jun 30, 2015 7:29 PM Flag

    What you are doing is picking up pennies in front of a road grader..

    Its you that's gonna need the luck

  • Reply to

    Excellent

    by frenzychess Jun 8, 2015 7:47 PM
    jesse.livermore jesse.livermore Jun 8, 2015 8:07 PM Flag

    Well stated....agree.

    Actually by running on so long and saying so little the FDA has managed to bring all their zany interpretations and perverted logic from the Oct 2013 AdCom into the trial. Something Amarin's stellar lawyers would have probably not been able to accomplish. FDA is a rare combination of arrogance and stupidity. They got slobber knocked by Judge Moss....

    Hello Chapter 2

    ": ) JL

    Sentiment: Strong Buy

  • Reply to

    Article about MAT9001 and Vascepa

    by onlyfactsplease Jun 3, 2015 6:11 PM
    jesse.livermore jesse.livermore Jun 5, 2015 9:52 AM Flag

    facts,...

    Please understand I do think DPA raises some serious questions about the future of w-3s as treatment for CVD and other chronic inflammatory diseases. Right now I do not know the answers to some of the questions, and am not sure the answers are known. For instance is DPA in essence (for all practical purposes) a metabolite of EPA ? Apparently DPA and EPA are inter convertible in humans. One article stated that is some interactions EPA is converted into DPA and it is DPA which is the active moiety. This raises the question of possible EPA benefits that DPA might not have . This might seem unfair, but at present the literature on EPA is vast and the literature on DPA is not vast.

    Does insuring adequate levels of EPA effectively solve the DPA deficiency problem?

    I am fascinated by your comment that MTNB can make DPA from other w-3s. Is that really true?
    Again the economies of supply are important. I guess they must be looking for the right
    algae.

    R-IT might obviate MTNB having to run an outcome trial, but that 's a big if...

    ": ) JL

  • Reply to

    Article about MAT9001 and Vascepa

    by onlyfactsplease Jun 3, 2015 6:11 PM
    jesse.livermore jesse.livermore Jun 3, 2015 9:34 PM Flag

    Dear facts...

    Suggest you stick to them...The MAT9001 story was not the lead story on the AMRN IHUB message board, That would be the FDA's actions on the First Amendment case.

    I would not get too excited about the article you cite. A standard plant to catch the suckers...Facts are...We don't even know the composition of MAT9001 so how can we come to any firm conclusion. We know it contains DPA and presumably its magic emanates from that particular N22 w-3. Even though EPA and DPA are inter convertible in humans, lets assume DPA...lowers PCSK9, lowers trigs and other non HDL_C lipid components, more than EPA, Lowers inflammation and oxidation more than EPA...the works...All things that remain unproven. This still does not necessarily make DPA a contender with EPA...We are not talking rare diseases here. In marine oils DPA averages about one tenth the amount of EPA...And don't start talking about killing the few seals that remain on the planet. To treat 10 million mixed dyslipidemia patients with 4 gms EPA requires 15% of the worlds annual production of fish oil. Currently the internet price for pure DPA is $350 for 300 mgs of DPA. The reason why MTNB's trial size was so small. I know a about the pathophysiology of w-3s in regards to lipids and CVD risk..I am not very impressed with this 28 person study over 14 days. Amarin is running a study with 7500 souls which is entering its forth year, and we still do not have enough data..

    MAT9001 has got a whole book full of questions it has to answer before it eats anyone's lunch...Maybe its you that has your head in the sand..

    ": ) JL

    Sentiment: Strong Sell

  • jesse.livermore by jesse.livermore Jun 1, 2015 6:35 PM Flag

    Results seem great, but not really all that important. First of all stop the nonsense and tell us what's in the mix. DPA and other omega-3s ??? so MAT9001 lowers trigs more than EPA....So does DHA. PCSK9 ? what does significant mean if MAT significantly lowers PCSK9 over Vascepa, if Vascepa does not lower PSCK9. How are they going to source DPA...currently the stuff sells on internet at over $350 for 300 mgs. The company has only 3.5 mil in assets and some debt. How did they even afford the 4gm DPA trial, the daily DPA was costing them $4 k./ day, per person that was $80 K per day for the trial..No wonder they cut down on enrollment and stopped the trial.

    ": ) JL

    Sentiment: Sell

  • Reply to

    BioBillionaire (Jason) from i-hub

    by rafunrafun Apr 30, 2015 5:16 PM
    jesse.livermore jesse.livermore May 1, 2015 8:01 AM Flag

    Jason, (BioBillionaire) never claimed he was a billionaire. He was a little over the top and given to outlandish statements like, I'm going to stick my boots up the FDA's #$%$. Or the they (the FDA principals) are going to jail. Stuff like that. Most of his predictions turned out to be wrong, but that's true of a lot of us.

    Jason was a good guy generally polite to most posters. He did comb through the government filings, particularly about our filing of a citizens petition to redress wrongs done by the FDA. Of course the FDA ended up throwing all our efforts in a big trash bucket, after a couple of lies and some BS arguments.

    He will be missed, and I hope they reinstate him soon. Interestly he is a paying member of Ihub, and usually they are immune to this kind of treatment. Don't know what he said, it was scrubbed very soon after. Maybe someone knows what the post said.

    ": ) JL

    Sentiment: Strong Buy

AMRN
2.50-0.02(-0.79%)Jul 6 4:00 PMEDT